357 related articles for article (PubMed ID: 30054790)
1. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.
Balloy G; Pelletier J; Suchet L; Lebrun C; Cohen M; Vermersch P; Zephir H; Duhin E; Gout O; Deschamps R; Le Page E; Edan G; Labauge P; Carra-Dallieres C; Rumbach L; Berger E; Lejeune P; Devos P; N'Kendjuo JB; Coustans M; Auffray-Calvier E; Daumas-Duport B; Michel L; Lefrere F; Laplaud DA; Brosset C; Derkinderen P; de Seze J; Wiertlewski S;
J Neurol; 2018 Oct; 265(10):2251-2259. PubMed ID: 30054790
[TBL] [Abstract][Full Text] [Related]
2. Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis.
Hardy TA; Tobin WO; Lucchinetti CF
Mult Scler; 2016 Jul; 22(8):986-92. PubMed ID: 27037180
[TBL] [Abstract][Full Text] [Related]
3. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Frederick MC; Cameron MH
Curr Neurol Neurosci Rep; 2016 Mar; 16(3):26. PubMed ID: 26847090
[TBL] [Abstract][Full Text] [Related]
4. Tumefactive demyelinating lesions.
Dagher AP; Smirniotopoulos J
Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
[TBL] [Abstract][Full Text] [Related]
5. Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.
Ayrignac X; Carra-Dallière C; Labauge P
Rev Neurol (Paris); 2018 Jun; 174(6):408-418. PubMed ID: 29673573
[TBL] [Abstract][Full Text] [Related]
6. Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics.
Arenas Vargas LE; Bedoya Morales AM; Rincón Carreño C; Espitia Segura OM; Penagos N
Mult Scler Relat Disord; 2020 Sep; 44():102198. PubMed ID: 32531753
[TBL] [Abstract][Full Text] [Related]
7. Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures.
Jarius S; Haas J; Paul F; Wildemann B
J Neuroinflammation; 2019 Feb; 16(1):51. PubMed ID: 30819213
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
[TBL] [Abstract][Full Text] [Related]
9. Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Pietroboni AM; Arighi A; De Riz MA; Ghezzi L; Calvi A; Avignone S; Scola E; Galimberti D; Triulzi F; Scarpini E
Neurol Sci; 2015 Dec; 36(12):2277-80. PubMed ID: 26109007
[TBL] [Abstract][Full Text] [Related]
10. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.
Lucchinetti CF; Gavrilova RH; Metz I; Parisi JE; Scheithauer BW; Weigand S; Thomsen K; Mandrekar J; Altintas A; Erickson BJ; König F; Giannini C; Lassmann H; Linbo L; Pittock SJ; Brück W
Brain; 2008 Jul; 131(Pt 7):1759-75. PubMed ID: 18535080
[TBL] [Abstract][Full Text] [Related]
11. Baló's concentric sclerosis - A rare entity within the spectrum of demyelinating diseases.
Xie JS; Jeeva-Patel T; Margolin E
J Neurol Sci; 2021 Sep; 428():117570. PubMed ID: 34261000
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic criteria of borderline forms of multiple sclerosis].
Dupel-Pottier C
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358
[TBL] [Abstract][Full Text] [Related]
13. Baló's concentric sclerosis and tumefactive demyelination: a shared immunopathogenesis?
Hardy TA; Beadnall HN; Sutton IJ; Mohamed A; Jonker BP; Buckland ME; Barnett MH
J Neurol Sci; 2015 Jan; 348(1-2):279-81. PubMed ID: 25475150
[TBL] [Abstract][Full Text] [Related]
14. Pediatric tumefactive multiple sclerosis case (with baló-like lesions), diagnostic and treatment challenges.
Kamari C; Galanakis E; Raissaki M; Briassoulis G; Vlachaki G; Vorgia P
Neurol Sci; 2023 Jan; 44(1):343-345. PubMed ID: 36171523
[TBL] [Abstract][Full Text] [Related]
15. Tumefactive Demyelination Lesions: Report on three cases.
Lin CJ; Lin SC; Yu KW; Ou Yang WY; Lee YC; Liao YC
Acta Neurol Taiwan; 2024 Dec; 33(4)():195-200. PubMed ID: 38073158
[TBL] [Abstract][Full Text] [Related]
16. [TUMOR-LIKE EFFECT AS INITIAL PRESENTATION OF PEDIATRIC MULTIPLE SCLEROSIS].
Menascu S; Pollak A; Warszawer Y; Bar-On S; Messika Gold N; Freed A; Dreyer Alster S; Vered D; Miron S; Achiron A
Harefuah; 2023 Dec; 162(10):660-665. PubMed ID: 38126150
[TBL] [Abstract][Full Text] [Related]
17. TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis.
Völk S; Unterrainer M; Albert NL; Havla J; Gerdes LA; Schumacher M; Brendel M; Kaiser L; Adorjan K; Rupprecht R; Bartenstein P; Kümpfel T; Danek A
Clin Nucl Med; 2020 Oct; 45(10):e447-e448. PubMed ID: 32796248
[TBL] [Abstract][Full Text] [Related]
18. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
19. Balò's concentric sclerosis presenting with benign clinical course and multiple sclerosis-like lesions on magnetic resonance images.
Li Y; Xie P; Fan X; Tang H
Neurol India; 2009; 57(1):66-8. PubMed ID: 19305082
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of Baló's concentric sclerosis: a study of eight cases with different therapeutic concepts.
Tzanetakos D; Vakrakou AG; Tzartos JS; Velonakis G; Evangelopoulos ME; Anagnostouli M; Koutsis G; Dardiotis E; Karavasilis E; Toulas P; Stefanis L; Kilidireas C
BMC Neurol; 2020 Nov; 20(1):400. PubMed ID: 33138795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
